ACRS - Aclaris Therapeutics EPS beats by $0.05 misses on revenue November, 04 2020 07:15 AM Aclaris Therapeutics Inc. Aclaris Therapeutics (ACRS): Q3 GAAP EPS of -$0.25 beats by $0.05.Revenue of $1.4M (+42.9% Y/Y) misses by $0.04M.Press Release For further details see: Aclaris Therapeutics EPS beats by $0.05, misses on revenue